Trial of Glioblastoma Immunotherapy Advancement with Nivolumab and Relatlimab(clinicaltrials.gov)

3 pointsby femto4 hours ago1 comment

femto4 hours ago
A more accessible explanation in the mainstream press:
https://www.smh.com.au/lifestyle/health-and-wellness/incredi...